Sponsor

Bolt Biotherapeutics, Inc.

Clinical research sponsor

Published trials3

Recruiting shown0

Roles1

SourceClinicalTrials.gov

Clinical trials

3 shown

Trial of BDC-1001 +/- Pertuzumab in Subjects With HER2-Positive Metastatic Breast CancerNCT05954143 · lead sponsor · 2023-11-30

TERMINATED

Study of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced MalignanciesNCT06052852 · lead sponsor · 2023-10-11

TERMINATED

A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid TumorsNCT04278144 · lead sponsor · 2020-02-24

TERMINATED

Sponsor roles

lead sponsor3

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.